Coronary artery disease association with serum concentration and genetic variation of MMP-9 in Ukrainian population

被引:0
|
作者
Pogorielova, O. [1 ]
Chumachenko, Y. A. [1 ]
Obukhova, O. [1 ]
Martsovenko, I. [2 ]
Harbuzova, V. [1 ]
机构
[1] Sumy State Univ, Inst Med, Sumy, Ukraine
[2] Sumy Reg Cardiol Clin, Sumy, Ukraine
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1338 / 1338
页数:1
相关论文
共 50 条
  • [31] Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease
    Mahmoodi, Khalil
    Kamali, Koorosh
    Karami, Elham
    Soltanpour, Mohammad Soleiman
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2017, 22
  • [32] Association of matrix metalloproteinases (MMP2, MMP7 and MMP9) genetic variants with left ventricular dysfunction in coronary artery disease patients
    Mishra, Avshesh
    Srivastava, Anshika
    Mittal, T.
    Garg, N.
    Mittal, B.
    [J]. CLINICA CHIMICA ACTA, 2012, 413 (19-20) : 1668 - 1674
  • [33] Adiponectin as a Negative Independent Predictor of MMP-9 (Matrix Metalloproteinase-9) in Serum Concentration
    Adamska, Agnieszka
    Nikolajuk, Agnieszka
    Karczewska-Kupczewska, Monika
    Otziomek, Elzbieta
    Gorska, Maria
    Kowalska, Irina
    Straczkowski, Marek
    [J]. DIABETES, 2012, 61 : A708 - A708
  • [34] The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome
    Lahdentausta, Laura
    Sorsa, Timo
    Pesonen, Erkki
    Pussinen, Pirkko
    [J]. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2018, 11 (06) : 526 - 527
  • [35] Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease
    Lamblin, N
    Bauters, C
    Hermant, X
    Lablanche, JM
    Helbecque, N
    Amouyel, P
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (01) : 43 - 48
  • [36] The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome
    Laura Lahdentausta
    Timo Sorsa
    Erkki Pesonen
    Pirkko Pussinen
    [J]. Journal of Cardiovascular Translational Research, 2018, 11 : 526 - 527
  • [37] The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome
    Gostiljac, D.
    Dordevic, P. B.
    Djuric, D.
    Perunicic, J.
    Lasica, R.
    Colak, E.
    Canovic, F.
    Sreckovic, V. D.
    Ilic, M.
    Obrenovic, R.
    [J]. ACTA PHYSIOLOGICA HUNGARICA, 2011, 98 (01) : 91 - 97
  • [38] Association between the-1562 C/T MMP-9 polymorphism and cerebrovascular disease in a Polish population
    Szczudlik, Piotr
    Borratynska, Anna
    [J]. NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2010, 44 (04) : 350 - 357
  • [39] MMP-9 SERUM LEVEL IN MDS DIAGNOSIS, PROGNOSIS AND DISEASE PROGRESSION
    Wilk, C. M.
    Kuendgen, A.
    Zilkens, C.
    Haas, R.
    Krauspe, R.
    Germing, U.
    Froebel, J.
    [J]. LEUKEMIA RESEARCH, 2015, 39 : S133 - S133
  • [40] Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease
    Shibata, N
    Ohnuma, T
    Higashi, S
    Usui, C
    Ohkubo, T
    Kitajima, A
    Ueki, A
    Nagao, M
    Arai, H
    [J]. NEUROBIOLOGY OF AGING, 2005, 26 (07) : 1011 - 1014